Liang Chang
Operating Partner at Foresite Labs · Cambridge, United States
Invests in AILiang Chang's investor profile lists AI alongside Healthcare & Biotech, at early-stage venture. No deals are on record yet, so this page lists the startup credits a company at these stages can claim.
Email InvestorCredits to line up before an early-stage round
Liang Chang backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:
Investment focus
- Backs startups in
- Artificial Intelligence, Healthcare & Biotech
- Rounds
- Early-stage venture
- Profile
- Venture investor
- Deals on record
- None yet
- Based in
- Cambridge, United States

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Alex IskoldFounder and Partner at 2048 Ventures
- Adam ValkinManaging Director at Vine Ventures
- Semyon DukachAngel investor in Boston
- Rajeev DhamManaging Director at Sapphire Ventures
- Konstantine BuhlerPartner @ Series D and Beyond at Waymo
- Randy WilliamsAngel investor in San Francisco
- Vaibhav AgrawalVenture investor in San Francisco
- Alice BrooksPartner at Khosla Ventures
Questions founders ask
- Does Liang Chang invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Liang Chang's investor profile, together with Healthcare & Biotech. The stages on record are early-stage venture.
- What credits can a startup claim before pitching Liang Chang?
- For a company raising an early-stage round, AI Perks lists credits such as IBM Cloud (up to $120,000), Redis (up to $10,000), WordPress VIP (up to $20,000) and Appwrite (up to $20,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal